Spironolactone
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
Ottawa Heart Institute Research Corporation
Overview
Spironolactone is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
Spironolactone clinical trials
Explore related
Medical disclaimer. This page summarizes research about Spironolactone for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.